Compassion-Focused Therapy for Prolonged Grief Symptoms
NCT ID: NCT03384615
Last Updated: 2020-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2018-01-03
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present study aims to develop, test and disseminate a group-based treatment manual for PGD in bereaved partners and their adult children. People with high levels of symptoms will be recruited from a large-scale survey study examining frequency, predictors and prognosis of PGD symptoms (NCT03049007). Participants will be randomized to group-based compassion-focused therapy (CFT) for grief or a waitlist control group. Treatment effects will be estimated with prolonged grief symptoms as the primary outcome. Secondary outcomes include depressive symptoms, posttraumatic stress symptoms, symptoms of anxiety, and quality-of-life. The investigators expect that CFT will yield statistically significant effects on prolonged grief symptom compared with the waitlist control group. If CFT is shown to be efficacious in reducing prolonged grief symptoms, the investigators will conduct moderation and mediation analyses with the aim of identifying what works, for whom. Finally, the investigators will perform cost-effectiveness analyses by linking the data with healthcare utilization data from the Danish National registries.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our primary hypotheses are:
• CFT will have a statistically significant and long-term effect on PGD symptoms compared with the waitlist control group
Secondary hypotheses are:
* Self-compassion self-criticism, rumination, and exposure to the loss will mediate the effects of CFT on PGD symptoms
* Baseline PGD symptom level will moderate the intervention effects of CFT, with higher symptom level predicting larger symptom improvement
* Gender, age, type of loss, attachment style, neuroticism, positive affect and social support will predict who will benefit most from treatment (moderator analyses)
* CFT will reduce levels of depression, anxiety, and posttraumatic stress symptoms and increase quality-of-life (QoL) compared with the wait-list control group
* Time spent on homework practice will moderate the intervention effects of CFT, with more time spent on homework predicting larger symptom improvement
* CFT is a cost-effective psychological treatment compared with the waitlist-control group
Design
The present project will be conducted as a randomized waitlist-controlled trial, with a 1:1 allocation ratio and using block randomization conducted by an external biostatistician.
Participants
The present randomized controlled trial (RCT) recruits patients from a large survey that invites all bereaved partners in the Central Denmark Region and their adult children (age \> 18 years) to participate in a survey regarding trajectories of grief. This means that the present study recruits patients from an existing survey (NCT03049007). All bereaved partners and their adult children from the existing survey study with clinically relevant levels of PGD 11 months after their loss (min.score \>= 25 on PG-13) will be invited to participate in the present RCT.
Assessment points
Assessment of all three intervention groups will be provided at five points: (1) before the intervention (baseline), (2) after each session (the CFT group only), (3) after the last intervention session (post-intervention), (4) 3 months post-intervention, and (5) 6 months post-intervention. In addition, data on healthcare utilization will be retrieved from the Danish registries concerning health care services (e.g., visit to the general practitioner, use of medication, number of hospitalizations).
Sample size
Previous studies have generally found large effects of psychological interventions for PGD that included cognitive techniques with effect-sizes (Cohens' d) ranging from 0.80-2.41. Although previous studies testing the efficacy of psychological treatments for prolonged grief have reported large effects, we undertake a more conservative estimate as CFT, so far, has not been tested in a bereaved population.
So far, no values for minimal clinically important difference (MCID) have been established for the PG-13. When such indicators are missing, the general literature on interpretation of clinical change suggests that a change corresponding to one half standard deviation could be a suitable substitute (Copay et al., 2007; Norman et al. 2003). We therefore aim to be able to detect a clinically relevant effect of Cohen's d 0.50. A final sample of 156 participants (2 x 78, 1:1 allocation) will enable us, in a pre-post repeated-measures design, to detect a difference between CFT and the control group, with a two-sided alpha of 0.05, a pre-post correlation (Rho) of 0.5, a statistical power of 0.80, and an estimated dropout rate of 20%.
Statistical analyses
Analyses will be conducted using the statistical software IBM SPSS statistics, v.21 (IMB, Chicago, IL) and Stata v.13 (StataCorp, College Stadium, TX). Baseline group differences will be explored with t tests and χ²-tests. All main effects will be analyzed using Mixed Linear Models (MLMs) based on the intent-to-treat sample, comparing groups over time on all outcome variables. Each hypothesis will be tested in separate models.
Intervention effects will be indicated by a statistically significant 2-way group x time interaction, and results will be interpreted in terms of their effect sizes. As we randomize the participants, we do not expect that any differences in use of alternative treatments prior to or during the study period will exist between study groups. However, in case of an imbalance on this variable, we will include it as a covariate in a second set of analyses.
Possible mediating and moderating effects will be explored for statistically significant outcomes in the main analyses, using MLMs. Cost-effectiveness analyses will be investigated by aggregating healthcare utilization costs and by investigating the effect of CFT on Quality-Adjusted Life-Years (QALY).The probability of CFT being cost-effective are investigated by calculating Cost-Effectiveness Acceptability Curves (CEACs).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Compassion-focused therapy
Compassion-Focused Therapy
CFT for PGD symptoms in the present project is inspired by two well-established CFT treatment manuals. The first is used for treatment of PTSD (Lee \& James, 2011) and the other for treatment of anger (Kolt, 2011). The manual for CFT for PGD adopts both structure and techniques from these into an 8-week, group-based program with weekly 2 1/4-hour sessions. Each session contains elements of psychoeducation on uncomplicated and prolonged grief reactions, identifying unhelpful strategies for self-protection and facilitating use of more helpful strategies, and training an open and compassionate management of grief-related distress through CFT exercises. Between the sessions the participant will train the exercises introduced at the previous session.
Waitlist control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Compassion-Focused Therapy
CFT for PGD symptoms in the present project is inspired by two well-established CFT treatment manuals. The first is used for treatment of PTSD (Lee \& James, 2011) and the other for treatment of anger (Kolt, 2011). The manual for CFT for PGD adopts both structure and techniques from these into an 8-week, group-based program with weekly 2 1/4-hour sessions. Each session contains elements of psychoeducation on uncomplicated and prolonged grief reactions, identifying unhelpful strategies for self-protection and facilitating use of more helpful strategies, and training an open and compassionate management of grief-related distress through CFT exercises. Between the sessions the participant will train the exercises introduced at the previous session.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Status of partner or child to the deceased
* A min. score of 25 on the PG-13 at 11 months after the loss
Exclusion Criteria
* Serious psychiatric disease, e.g., schizophrenia, bipolar disease
* Acute suicidal ideation
* Serious cognitive impairment, e.g., Alzheimer's disease
* Active treatment for serious disease, e.g., chemotherapy for cancer
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Utrecht University
OTHER
Columbia University
OTHER
University of Southern Denmark
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maja O'Connor, MSc., PhD
Role: STUDY_DIRECTOR
University of Aarhus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unit for Bereavement Research, Dept. of Psychology, Aarhus University
Aarhus C, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Link to the research unit's website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TABs
Identifier Type: -
Identifier Source: org_study_id